By:
On:
In: Business, કોર્પોરેટ ન્યૂઝ

AHMEDABAD, November 14th: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD),Continue Reading

By:
On:
In: Business, કોર્પોરેટ ન્યૂઝ

AHMEDABAD, 11THNovember: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System. The approved ANDA is therapeutically equivalent to theContinue Reading

By:
On:
In: Business, કોર્પોરેટ ન્યૂઝ

AHMEDABAD, 08 October: Alembic Pharmaceuticals Ltd., through a strategic agreement with Amlan International, today announced the India launch of MinerTox-Z and MinerTox-A, feed additive solutions developed to protect poultry against toxins and enhance farm productivity. The introduction of these products represents an important step in addressing one of the poultryContinue Reading

By:
On:
In: કોર્પોરેટ ન્યૂઝ, શેર બજાર

MUMBAI, 4 JULY:   Insecticides India: CRISIL upgrades long-term credit rating from ‘CRISIL A/Stable’ to ‘CRISIL A+/Stable’.  (Positive) ONGC: Company & Mitsui O.S.K. Lines signed a Heads of Agreement on July 3, 2025, to build & operate two Very Large Ethane Carriers. (Positive) Indian Energy Exchange: Company Reports 15% YoYContinue Reading